Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Friday Nov 05, 2021
Friday Nov 05, 2021
touchPANEL DISCUSSION for touchONCOLOGY
Listen to leading experts review the latest advances in HR+ breast cancer, focusing on the management of specific patient subgroups and the potential impact of emerging oral, second-generation SERDs on patient standard of care.
The experts
- Prof. Hope S Rugo – UCSF Comprehensive Cancer Center, San Francisco, CA, USA
- Dr Fatima Cardoso – Champalimaud Clinical Center, Lisbon, Portugal
- Dr Matti Aapro – Genolier Cancer Center, Genolier, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Sanofi Genzyme. This activity is provided by touchIME.
For further information visit our website: https://touchoncologyime.org/emerging-serds-for-treating-hr-positive-breast-cancer/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.